A robust agenda to decide the future of healthcare in Europe looms large over the upcoming elections to the European Parliament in May.

President Trump’s latest proposal would allow health insurance plans to limit the HIV/AIDs medications they cover through Medicare Part D. Patients relying on Medicare Part D, would be one of six “protected classes” now denied access to their needed medicines. The proposal is shortsighted, as it surely will not save the costs projected in the proposed budget.